Franco-Nevada Corporation (FNV:CA) Q2 2026 Earnings Call Transcript

SA Transcripts 161.77K Followers Follow Franco-Nevada Corporation ( FNV:CA ) Q2 2026 Earnings Call August 12, 2026 8:00 AM EDT Company Participants Bonavie Tek - Vice President of Finance & Investor Relations Paul Brink - President, CEO & Director Sandip Rana - Chief Financial Officer Eaun Gray - Chief Investment Officer Matthew Begeman - Vice President of Business Development Lloyd Hong - Chief Legal Officer & Corporate Secretary Conference Call Participants Cosmos Chiu - CIBC Capital Markets, Research Division Lawson Winder - BofA Securities, Research Division Daniel Major - UBS Investment Bank, Research Division Tanya Jakusconek - Scotiabank Global Banking and Markets, Research Division Brian MacArthur - Raymond James Ltd., Research Division Presentation Operator Good morning, and welcome to Franco-Nevada Corporation's Second Quarter 2026 Results Conference Call and Webcast. This call is being recorded on August 12, 2026. [Operator Instructions] I would now like to turn the conference over to your host, Bonavie Tek, VP, Finance and Investor Relations. Please go ahead. Bonavie Tek Vice President of Finance & Investor Relations Thank you, [ Anis ]. Good morning, everyone. Thank you for joining us today to discuss Franco-Nevada's Second Quarter 2026 results. Accompanying this call is a presentation, which is available on our website at franco-nevada.com, where you will also find our full financial results. The presentation is also available to view on the webcast. During our call this morning, Paul Brink, President and CEO of Franco-Nevada, will provide introductory remarks; followed by Sandip Rana, Chief Financial Officer, who will provide a brief review of our results. This will be followed by a Q&A period. Our executive team is available to answer any questions. Participants may submit questions by telephone or via the webcast. We would like to remind participants that some of today's commentary may contain forward-looking information, and we refer you to our detailed cautionary note on Slide 2 of this presentation. I will